Sandy Draper
Stock Analyst at Guggenheim
(2.92)
# 1,392
Out of 5,161 analysts
113
Total ratings
59.14%
Success rate
20.63%
Average return
Main Sectors:
Stocks Rated by Sandy Draper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Maintains: Buy | $464 → $432 | $443.85 | -2.67% | 12 | Jul 24, 2024 | |
| EVH Evolent Health | Maintains: Hold | $34 → $28 | $3.06 | +815.03% | 10 | May 14, 2024 | |
| IQV IQVIA Holdings | Downgrades: Neutral | n/a | $162.93 | - | 8 | Feb 15, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Neutral | n/a | $152.66 | - | 15 | Feb 15, 2024 | |
| GDRX GoodRx Holdings | Maintains: Buy | $8 → $10 | $2.21 | +352.49% | 4 | Aug 10, 2023 | |
| DOCS Doximity | Downgrades: Neutral | n/a | $24.28 | - | 3 | Aug 9, 2023 | |
| TOI The Oncology Institute | Maintains: Buy | $3 → $2 | $2.62 | -23.66% | 3 | Jun 16, 2023 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $271 → $263 | $97.45 | +169.88% | 13 | Apr 28, 2023 | |
| AGL agilon health | Maintains: Buy | $21 → $30 | $0.60 | +4,859.50% | 3 | Mar 6, 2023 | |
| HQY HealthEquity | Maintains: Buy | $89 → $94 | $76.79 | +22.41% | 11 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $5.36 | - | 10 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $51 | $21.73 | +134.70% | 2 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $143 → $129 | $190.31 | -32.22% | 2 | May 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $55 | $30.93 | +77.82% | 2 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $226 → $168 | $103.27 | +62.68% | 2 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $12 | $23.84 | -49.66% | 1 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $6.59 | +658.73% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $65 | $7.98 | +714.54% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $1.79 | +1,911.17% | 4 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $167 | $180.79 | -7.63% | 3 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $0.79 | - | 2 | May 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $63 | $7.59 | +730.04% | 1 | Sep 20, 2016 |
Medpace Holdings
Jul 24, 2024
Maintains: Buy
Price Target: $464 → $432
Current: $443.85
Upside: -2.67%
Evolent Health
May 14, 2024
Maintains: Hold
Price Target: $34 → $28
Current: $3.06
Upside: +815.03%
IQVIA Holdings
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $162.93
Upside: -
Charles River Laboratories International
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $152.66
Upside: -
GoodRx Holdings
Aug 10, 2023
Maintains: Buy
Price Target: $8 → $10
Current: $2.21
Upside: +352.49%
Doximity
Aug 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $24.28
Upside: -
The Oncology Institute
Jun 16, 2023
Maintains: Buy
Price Target: $3 → $2
Current: $2.62
Upside: -23.66%
ICON Public Limited Company
Apr 28, 2023
Maintains: Buy
Price Target: $271 → $263
Current: $97.45
Upside: +169.88%
agilon health
Mar 6, 2023
Maintains: Buy
Price Target: $21 → $30
Current: $0.60
Upside: +4,859.50%
HealthEquity
Dec 7, 2022
Maintains: Buy
Price Target: $89 → $94
Current: $76.79
Upside: +22.41%
Oct 24, 2022
Upgrades: Neutral
Price Target: n/a
Current: $5.36
Upside: -
Aug 12, 2022
Maintains: Buy
Price Target: $36 → $51
Current: $21.73
Upside: +134.70%
May 25, 2021
Maintains: Buy
Price Target: $143 → $129
Current: $190.31
Upside: -32.22%
May 18, 2021
Maintains: Buy
Price Target: $84 → $55
Current: $30.93
Upside: +77.82%
May 12, 2021
Maintains: Buy
Price Target: $226 → $168
Current: $103.27
Upside: +62.68%
Apr 21, 2021
Initiates: Hold
Price Target: $12
Current: $23.84
Upside: -49.66%
Jan 28, 2021
Initiates: Buy
Price Target: $50
Current: $6.59
Upside: +658.73%
Jan 28, 2021
Initiates: Buy
Price Target: $65
Current: $7.98
Upside: +714.54%
May 13, 2020
Maintains: Buy
Price Target: $30 → $36
Current: $1.79
Upside: +1,911.17%
Mar 26, 2020
Maintains: Buy
Price Target: $175 → $167
Current: $180.79
Upside: -7.63%
May 31, 2017
Upgrades: Buy
Price Target: n/a
Current: $0.79
Upside: -
Sep 20, 2016
Initiates: Buy
Price Target: $63
Current: $7.59
Upside: +730.04%